HIV-1 Latency Is Maintained by the Estrogen Receptor

被引:1
|
作者
Bick, Alexis J. [1 ]
Hapgood, Janet P. [1 ,2 ]
机构
[1] Univ Cape Town, Dept Mol & Cell Biol, Cape Town, South Africa
[2] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa
关键词
TRANSCRIPTION;
D O I
10.1016/j.tim.2018.09.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Persistence of the latent reservoir remains a challenge to curing HIV infection. Using shRNA screening, new insights into the molecular mechanisms underlying latency regulation indicate that the estrogen receptor is a potent repressor of proviral reactivation and may serve as a promising therapeutic target in combination with other latency-reversing agents.
引用
收藏
页码:891 / 892
页数:2
相关论文
共 50 条
  • [41] Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency
    Gornalusse, German Gustavo
    Vojtech, Lucia N.
    Levy, Claire N.
    Hughes, Sean M.
    Kim, Yeseul
    Valdez, Rogelio
    Pandey, Urvashi
    Ochsenbauer, Christina
    Astronomo, Rena
    McElrath, Julie
    Hladik, Florian
    VIRUSES-BASEL, 2021, 13 (08):
  • [42] Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency
    Jean, Maxime Junior
    Power, Derek
    Kong, Weili
    Huang, Huachao
    Santoso, Netty
    Zhu, Jian
    VIRUSES-BASEL, 2017, 9 (04):
  • [43] A novel model for proviral HIV-1 latency in neural cells reveals similarities between HIV-1 latency in the brain and in the immune system
    Schneider, Martha
    Ziegenhain, Christoph
    Tigges, Bianca
    Helfer, Markus
    Brack-Werner, Ruth
    JOURNAL OF NEUROVIROLOGY, 2013, 19 : S73 - S74
  • [44] Mathematical Models of HIV-1 Dynamics, Transcription, and Latency
    D'Orso, Ivan
    Forst, Christian V.
    VIRUSES-BASEL, 2023, 15 (10):
  • [45] Unravelling HIV-1 Latency, One Cell at a Time
    Kok, Yik Lim
    Ciuffi, Angela
    Metzner, Karin J.
    TRENDS IN MICROBIOLOGY, 2017, 25 (11) : 932 - 941
  • [46] HIV-1 LATENCY DUE TO THE SITE OF PROVIRAL INTEGRATION
    WINSLOW, BJ
    POMERANTZ, RJ
    BAGASRA, O
    TRONO, D
    VIROLOGY, 1993, 196 (02) : 849 - 854
  • [47] A new in vitro system to model HIV-1 latency
    Marini, A.
    Romerio, F.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A100 - A100
  • [48] Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
    McLaurin, Kristen A.
    Moran, Landhing M.
    Booze, Rosemarie M.
    Mactutus, Charles F.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2020, 15 (02) : 264 - 279
  • [49] HIV-1 latency in activated T-cells.
    Berkhout, Ben
    RETROVIROLOGY, 2013, 10 : S5 - S5
  • [50] Transcriptional Stochasticity as a Key Aspect of HIV-1 Latency
    Damour, Alexia
    Slaninova, Vera
    Radulescu, Ovidiu
    Bertrand, Edouard
    Basyuk, Eugenia
    VIRUSES-BASEL, 2023, 15 (09):